Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia

PURPOSE: Teriparatide is used to treat patients with established osteoporosis but is often reserved for patients who have inadequate response to antiresorptive therapy. Biosimilar teriparatide, which is believed to have efficacy and safety similar to the originator product, is now available in Colom...

Descripción completa

Detalles Bibliográficos
Autores principales: Graham-Clarke, Peita L, Hauber, Brett, Boeri, Marco, Leonardi, Felice, Burge, Russel T, Fernandez, Maria, Tockhorn-Heidenreich, Antje, Florez, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323574/
https://www.ncbi.nlm.nih.gov/pubmed/32612354
http://dx.doi.org/10.2147/PPA.S250745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323574/
https://www.ncbi.nlm.nih.gov/pubmed/32612354
http://dx.doi.org/10.2147/PPA.S250745

Ejemplares similares